Understanding how a specific protein affects blood vessel inflammation after COVID-19
Kmt2a/MLL1 regulation of endothelial activation
['FUNDING_R01'] · UNIVERSITY OF MICHIGAN AT ANN ARBOR · NIH-11105854
This study is looking at how a protein called MLL1 affects inflammation in blood vessels after severe COVID-19, with the hope of finding new treatments for patients dealing with related complications.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MICHIGAN AT ANN ARBOR (nih funded) |
| Locations | 1 site (ANN ARBOR, UNITED STATES) |
| Trial ID | NIH-11105854 on ClinicalTrials.gov |
What this research studies
This research investigates the role of a protein called MLL1 in the inflammation of blood vessels, known as endotheliitis, which can occur after severe COVID-19 infections. By studying human samples and animal models, the researchers aim to identify how MLL1 influences the expression of genes related to blood vessel function and clotting. The goal is to uncover specific mechanisms that could lead to targeted therapies for patients suffering from complications related to COVID-19. This work is crucial as current treatments are limited and often have significant side effects.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients who have experienced severe COVID-19 infections and are suffering from complications related to blood vessel inflammation.
Not a fit: Patients who have not been infected with SARS-CoV-2 or those with mild COVID-19 symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of targeted therapies that specifically address the complications of COVID-19 related endotheliitis, improving patient outcomes.
How similar studies have performed: Other research has shown promise in targeting specific pathways involved in endothelial dysfunction, suggesting that this approach could be effective.
Where this research is happening
ANN ARBOR, UNITED STATES
- UNIVERSITY OF MICHIGAN AT ANN ARBOR — ANN ARBOR, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: OBI, ANDREA TARA — UNIVERSITY OF MICHIGAN AT ANN ARBOR
- Study coordinator: OBI, ANDREA TARA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: after COVID-19 infection, after infection by SARS-CoV-2, after SARS-CoV-2 infection, after SARS-CoV2 infection, after severe acute respiratory distress syndrome CoV-2 infection